Celsion Corporation (CLSN)

[GD]

Unfortunately, my suspicion of 42 month time mark
PFS cross over down come true to the worst outcome,
which means Thermodox arm patients has same or more
PFS patients after 42 month in the trial and no fat
OS KM tail to drive up efficacy, hence this look has
to stop the trial. I escaped second time, CLSN's
offering action and words in the last PR did give
me a hint.